Send a text

Sickle cell disease is a group of inherited disorders that affect hemoglobin, the major protein that carries oxygen in red blood cells. The disease affects more than 100,000 people in the U.S., including those who are non-Hispanic Black or African American, Hispanic or Latino and also affects people from the Mediterranean and Southeast Asia, and Arabs. Lukeman Tijani, M.D., is a hematologist oncologist with Texas Tech Physicians. He describes what sickle cell disease is and does to the organs; screenings, symptoms and treatment; why it's important for those with sickle cell disease to see a physician in the early stages of family planning and debunks myths about the disease.

Send a text

As GLP-1 medications become available in pill form, some people might be curious to try them. Drew Payne, D.O., an internal medicine physician with Texas Tech Physicians, explains what these and other weight loss medications and procedures do and their effects on type 2 diabetes. He also talks about what happens when patients stop taking these medications and stresses why it's important to get treatment from a physician who can help with weight loss goals while keeping the patient's health a priority.

Send a text

According to a new study from the American Cancer Society, more people are reaching the 5-year milestone following a cancer diagnosis. The report states that seven in 10 people now live five years after their diagnosis. Why is that 5-year important? Why have survival rates improved dramatically? That’s what our expert for this episode is here to tell us. Jasmine Sekhon, M.D., is a hematologist and oncologist with Texas Tech Physicians. She gives us insight into which cancers are still lagging behind this 5-year milestone and why and what part screenings play when it comes to survival rates.